Northeast Georgia Medical Center to Implement eGlycemic Management System® from Glytec

JULY 30, 2019

Northeast Georgia Medical Center to Implement eGlycemic Management System® from Glytec

The not-for-profit community medical center is partnering with Glytec to facilitate standardization of best practices in diabetes therapy management.

Waltham, MA — With as many as half of critical care patients either diagnosed with diabetes or at risk of hyperglycemia while hospitalized, Northeast Georgia Medical Center, in partnership with Glytec, is taking advanced measures to optimize glycemic management and ensure the safety and efficacy of insulin therapy. “Our organization is steadfastly committed to clinical excellence in diabetes care and glycemic management,” says Dr. Suhel Patel, Medical Director and Chair, Inpatient Medicine, Northeast Georgia Physicians Group. “By adopting the Glytec suite of technologies and services, our patients will receive insulin therapy that is personalized to their individual needs and carefully designed to support their recovery and transitions of care.”

The medical center has realized many notable improvements in glycemic outcomes through its involvement with the Society of Hospital Medicine (SHM). The new partnership with Glytec will augment SHM-recommended operational and educational initiatives and allow for a more comprehensive systems approach. “Investing in Glytec’s solution suite is an important next step in helping us achieve and sustain standardization of best practices,” says Patel. “With the eGlycemic Management System®, we’ll have a single platform for managing insulin therapy across all of our acute care facilities, and it will be interoperable with our Epic EMR, which means every clinician will be equipped to execute against best practices at all times, no matter where they are.”

Data from more than 150,000 annual patient encounters and more than 65 studies have shown that Glytec’s eGlycemic Management System® results in faster times to target glucose levels and lower incidence of hypoglycemia and hyperglycemia when compared to usual care comprising static protocols.

“Challenges surrounding insulin therapy are well documented in the medical literature, and as a high-alert medication, considerable safety precautions are imperative,” explains Cindy Danner, Associate Chief Nursing Officer, Northeast Georgia Medical Center Gainesville Campus. “We are confident the eGlycemic Management System® will elevate our nurses’ ability to deliver the very best care to every patient and will remove many of the difficulties and demands posed by manual processes. We also anticipate the system will increase staff satisfaction and engagement.”

Implementation of the eGlycemic Management System® will be governed by the health system’s Diabetes Core Team, a multidisciplinary glycemic steering committee led by Patel. “Our Diabetes Core Team was instrumental in the decision to partner with Glytec,” says Patel, “and our Diabetes Program Manager, Hannah Day, who directed the value analysis process, will be a key facilitator in getting the eGlycemic Management System® up and running.”

Members of Glytec’s Clinical Services and Quality Initiatives teams will work with Northeast Georgia Medical Center to tailor glycemic management workflows and order sets. They will also configure an analytics program around key performance indicators consistent with desired outcomes and targeted improvements.

“This is a significant initiative for our nursing organization,” says Danner, “Insulin is one of the most prescribed therapies in the inpatient setting, and we are excited by the many benefits of Glytec’s technology-enabled approach.”

About Glytec

Founded in 2006, Glytec is the pioneer of digital therapeutics, improving the lives of people with diabetes by making insulin a more effective and accessible option for millions unable to achieve their treatment goals. The company’s patented eGlycemic Management System® is the only FDA-cleared software-as-a-medical-device (SaMD) platform to enable the mass personalization of insulin across the continuum of care: inpatient, outpatient and virtual settings alike. Glytec offers several comprehensive programs combining evidence-based decision support technologies with expert professional services proven to aid providers in achieving best practices and standardization while reducing hyperglycemia, hypoglycemia, A1C, readmissions, length of stay and cost. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information visit

View on Business Wire